This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom
The drug MIMPARA contains one active pharmaceutical ingredient (API):
1
Cinacalcet
UNII 1K860WSG25 - CINACALCET HYDROCHLORIDE
|
Cinacalcet is a calcimimetic agent which directly lowers PTH levels by increasing the sensitivity of the calcium sensing receptor to extracellular calcium. The reduction in PTH is associated with a concomitant decrease in serum calcium levels. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MIMPARA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H05BX01 | Cinacalcet | H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 544115030000017, 544115030000117, 544115030000217 |
Country: EE | Ravimiamet | Identifier(s): 1205121, 1205132, 1205143, 1205154, 1205165, 1205176, 1205187, 1205198, 1205200, 1205211, 1205222, 1205233, 1753039, 1753040, 1753051 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 04292002, 04292006, 04292010, 104292013, 104292014, 104292015 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 444217, 453891, 549575 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60632346, 60889903, 61326733, 63023578, 63293417, 68434003 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 375973, 375976, 375979, 89555, 89573, 89596 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 88409, 88422, 88463, 88724 |
Country: IT | Agenzia del Farmaco | Identifier(s): 036598023, 036598050, 036598098 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1029794, 1029795, 1029796, 1029797, 1029798, 1029799, 1029800, 1029801, 1029802, 1029803, 1029804, 1029805, 1050909, 1050912, 1083926, 1083927, 1083928 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 213M2011 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 161446, 161454, 161462, 77100, 77119, 77127 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100102921, 100103984, 100104966, 100418050, 100418067, 100418073 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W43185002, W43186002 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699862090100, 8699862090117, 8699862090124 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.